A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your GYN Cancer questions.
Dr. Sarah Temkin’s Bio | Q&A Archive
Cancer - perineum
Imiquimod 5% cream may be used to treat vulvar intraepithelial neoplasia (VIN).
Treatment involves surgery to remove the cancer cells. If the tumor is large (more than 2 cm) or has grown deeply into the skin, the lymph nodes in the groin area may also be removed.
Radiation, with or without chemotherapy, may be used to treat advanced tumors or vulvar cancer that comes back.
You can ease the stress of illness by joining a support group whose members share common experiences and problems. See cancer - support group.
Most women with vulvar cancer who are diagnosed and treated at an early stage do well. However, a woman's outcome depends on:
The cancer commonly comes back at or near the site of the original tumor.
Complications may include:
Call your health care provider if you have any of these symptoms for more than 2 weeks:
Zhingran A, Russell AH, Seiden MV, et al. Cancers of the cervix, vulva, and vagina. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 91.
Kumar S, Shah JP, Bryant CS, et al. A comparison of younger vs older women with vulvar cancer in the United States. Am J Obstet Gynecol. 2009;200:e52-e55.
van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med. 2008;358:1465-1473.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885